The anomalous magnetic moment of the negative muon has been measured to a precision of 0.7 ppm (ppm) at the Brookhaven Alternating Gradient Synchrotron. This result is based on data collected in ...2001, and is over an order of magnitude more precise than the previous measurement for the negative muon. The result a(mu(-))=11 659 214(8)(3) x 10(-10) (0.7 ppm), where the first uncertainty is statistical and the second is systematic, is consistent with previous measurements of the anomaly for the positive and the negative muon. The average of the measurements of the muon anomaly is a(mu)(exp)=11 659 208(6) x 10(-10) (0.5 ppm).
A
bstract
The cross section of the process
e
+
e
−
→
π
+
π
−
has been measured in the Spherical Neutral Detector (SND) experiment at the VEPP-2000
e
+
e
−
collider VEPP-2000 in the energy region 525
...<
s
<
883 MeV. The measurement is based on data with an integrated luminosity of about 4.6 pb
−
1
. The systematic uncertainty of the cross section determination is 0.8% at
s
>
0
.
600 GeV. The
ρ
meson parameters are obtained as
m
ρ
= 775
.
3 ± 0
.
5 ± 0
.
6 MeV, Γ
ρ
= 145
.
6 ± 0
.
6 ± 0
.
8 MeV,
B
ρ
→
e
+
e−
×
B
ρ
→
π
+
π−
= (4
.
89 ± 0
.
02 ± 0
.
04) × 10
−
5
, and the parameters of the
e
+
e
−
→
ω
→
π
+
π
−
process, suppressed by
G
-parity, as
B
ω
→
e
+
e−
×
B
ω
→
π
+
π−
= (1
.
32 ± 0
.
06 ± 0
.
02) × 10
−
6
and and
ϕ
ρω
= 110
.
7 ± 1
.
5 ± 1
.
0 degrees.
A higher precision measurement of the anomalous g value, a(mu)=(g-2)/2, for the positive muon has been made at the Brookhaven Alternating Gradient Synchrotron, based on data collected in the year ...2000. The result a(mu(+))=11 659 204(7)(5)x10(-10) (0.7 ppm) is in good agreement with previous measurements and has an error about one-half that of the combined previous data. The present world average experimental value is a(mu)(expt)=11 659 203(8)x10(-10) (0.7 ppm).
A precise measurement of the anomalous g value, a(mu) = (g-2)/2, for the positive muon has been made at the Brookhaven Alternating Gradient Synchrotron. The result a(mu+) = 11 659 202(14) (6) x ...10(-10) (1.3 ppm) is in good agreement with previous measurements and has an error one third that of the combined previous data. The current theoretical value from the standard model is a(mu)(SM) = 11 659 159.6(6.7) x 10(-10) (0.57 ppm) and a(mu)(exp) - a(mu)(SM) = 43(16) x 10(-10) in which a(mu)(exp) is the world average experimental value.
The updated results of the precise measurements of the processes e+e−→ρ→π+π−, e+e−→ω→π+π−π0 and e+e−→φ→K0LK0S performed by the CMD-2 Collaboration are presented. The update appeared necessary due to ...an overestimate of the integrated luminosity in previous analyses.
Abstract
This paper introduces a new approach to measure the muon magnetic moment anomaly $a_{\mu} = (g-2)/2$ and the muon electric dipole moment (EDM) $d_{\mu}$ at the J-PARC muon facility. The goal ...of our experiment is to measure $a_{\mu}$ and $d_{\mu}$ using an independent method with a factor of 10 lower muon momentum, and a factor of 20 smaller diameter storage-ring solenoid compared with previous and ongoing muon $g-2$ experiments with unprecedented quality of the storage magnetic field. Additional significant differences from the present experimental method include a factor of 1000 smaller transverse emittance of the muon beam (reaccelerated thermal muon beam), its efficient vertical injection into the solenoid, and tracking each decay positron from muon decay to obtain its momentum vector. The precision goal for $a_{\mu}$ is a statistical uncertainty of 450 parts per billion (ppb), similar to the present experimental uncertainty, and a systematic uncertainty less than 70 ppb. The goal for EDM is a sensitivity of $1.5\times 10^{-21}~e\cdot\mbox{cm}$.
Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease for which the genetic contribution is incompletely understood.
We conducted a joint analysis of 5,523,934 imputed SNPs in two ...newly-genotyped progressive supranuclear palsy cohorts, primarily derived from two clinical trials (Allon davunetide and NNIPPS riluzole trials in PSP) and a previously published genome-wide association study (GWAS), in total comprising 1646 cases and 10,662 controls of European ancestry.
We identified 5 associated loci at a genome-wide significance threshold P < 5 × 10
, including replication of 3 loci from previous studies and 2 novel loci at 6p21.1 and 12p12.1 (near RUNX2 and SLCO1A2, respectively). At the 17q21.31 locus, stepwise regression analysis confirmed the presence of multiple independent loci (localized near MAPT and KANSL1). An additional 4 loci were highly suggestive of association (P < 1 × 10
). We analyzed the genetic correlation with multiple neurodegenerative diseases, and found that PSP had shared polygenic heritability with Parkinson's disease and amyotrophic lateral sclerosis.
In total, we identified 6 additional significant or suggestive SNP associations with PSP, and discovered genetic overlap with other neurodegenerative diseases. These findings clarify the pathogenesis and genetic architecture of PSP.
PDF
